Annotation Detail for MTMR14
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| PWY-6367 | D-myo-inositol-5-phosphate metabolism |
| PWY-6368 | 3-phosphoinositide degradation |
| Desease Name |
|---|
| Centronuclear myopathy, autosomal, modifier of |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C025643 |
vinclozolin |
vinclozolin results in increased methylation of MTMR14 gene | increases methylation | 16973722
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
4.10 | 19015723 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
5.13 | 14966744 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
6.02 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
6.72 | 16417039 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.38 | 16467254 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.82 | 16417039 |
| OMIM:160150 |
MYOPATHY, CENTRONUCLEAR, 1 |
marker/mechanism |
|
| |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.98 | 19015723 18220299 18042343 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
6.02 | 18220299 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
6.02 | 18629315 |
Pharmacogenomics Knowledge Base